EUVIMEDEUVIMED entdecken
Multizentrische Studie

Racial disparities in the pharmacological treatment of insomnia: A time-to-event analysis using real-world data

Emma Holler, Noll L Campbell, Malaz Boustani, Paul Dexter, Zina Ben Miled, Arthur Owora

Sleep Health · 2023

DOI: 10.1016/j.sleh.2023.02.002 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Sleep Health, 2023. Verfasst von Emma Holler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Indiana University Bloomington, Bloomington, Indiana, USA. Electronic address: emorone@iu.edu. Hauptthemen laut MEDLINE: Racial Groups, Sleep Initiation and Maintenance Disorders, Healthcare Disparities, Hypnotics and Sedatives. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: NHLBI NIH HHS, Merck Sharp and Dohme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Examine the association between race and time to pharmacologic treatment of insomnia in a large multi-institutional cohort. METHODS: Retrospective analysis of electronic medical records from a regional health information exchange. Eligible patients included adults with at least one healthcare visit per year from 2010 to 2019, a new insomnia diagnosis code during the study period, and no prior insomnia diagnosis codes or medications. A Cox frailty model was used to examine the association between race and time to an insomnia medication after diagnosis. RESULTS: In total, 9557 patients were analyzed, 7773 (81.3%) of whom where White, 1294 (13.5%) Black, 238 (2.5%) Other, and 252 (2.6%) unknown race. About 6.2% of Black and 8% of Other race patients received an order for a Food and Drug Administration-approved insomnia medication after diagnosis compared with 13.5% of White patients. Black patients were significantly less likely to have an order for a Food and Drug Administration-approved insomnia medication at all time points (adjusted hazard ratio [aHR] range: 0.37-0.73), and patients reporting Other race were less likely to have received an order at 2 (aHR 0.51, 95% confidence interval [CI] 0.28-0.94), 3 (aHR 0.33, 95% CI 0.13-0.79), and 4 years (aHR 0.21, 95% CI 0.06-0.71) of follow-up. Similar results were observed in a sensitivity analysis including off-label medications. CONCLUSIONS: Patients belonging to racial minority groups are less likely to be prescribed an insomnia medication than White patients after accounting for sociodemographic and clinical factors. Further research is needed to determine the extent to which patient preferences and physician perceptions affect these prescribing patterns and investigate potential disparities in nonpharmacologic treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Racial GroupsSleep Initiation and Maintenance DisordersHealthcare DisparitiesHypnotics and SedativesPractice Patterns, Physicians'Time-to-TreatmentAdultHumansBlack PeopleMinority GroupsRetrospective StudiesWhiteUnited StatesBlack or African American

Stichwörter der Autor:innen

Electronic health recordsHealth disparitiesInsomniaMedicationSleep disorders

Substanzen

Hypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Indiana University Bloomington, Bloomington, Indiana, USA. Electronic address: emorone@iu.edu.
  • College of Pharmacy and Health Sciences, Purdue University, West Lafayette, Indiana, USA; Indiana University Center for Aging Research, Regenstrief Institute, Indianapolis, Indiana, USA; Center for Healthcare Innovation…
  • Indiana University Center for Aging Research, Regenstrief Institute, Indianapolis, Indiana, USA; Center for Healthcare Innovation and Implementation Science, Indiana University, Indianapolis, Indiana, USA; Department of…
  • Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA; Clem McDonald Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.
  • Department of Electrical and Computer Engineering, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, USA.
  • Department of Epidemiology and Biostatistics, Indiana University Bloomington, Bloomington, Indiana, USA.

Förderung

  • NHLBI NIH HHS
  • Merck Sharp and Dohme

Zitieren

APA

Holler, E., Campbell, N. L., Boustani, M., Dexter, P., Ben Miled, Z., & Owora, A. (2023). Racial disparities in the pharmacological treatment of insomnia: A time-to-event analysis using real-world data. Sleep Health. https://doi.org/10.1016/j.sleh.2023.02.002

Vancouver

Holler E, Campbell NL, Boustani M, Dexter P, Ben Miled Z, Owora A. Racial disparities in the pharmacological treatment of insomnia: A time-to-event analysis using real-world data. Sleep Health. 2023. doi:10.1016/j.sleh.2023.02.002

BibTeX
@article{Holler2023,
  author = {Holler, Emma and Campbell, Noll L and Boustani, Malaz and Dexter, Paul and Ben Miled, Zina and Owora, Arthur},
  title = {Racial disparities in the pharmacological treatment of insomnia: A time-to-event analysis using real-world data},
  journal = {Sleep Health},
  year = {2023},
  doi = {10.1016/j.sleh.2023.02.002}
}
Kostenlos starten →